Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PAMIDRONATE for Bone density decreased: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 39 adverse event reports in the FDA FAERS database where PAMIDRONATE was used for Bone density decreased.

Most Reported Side Effects for PAMIDRONATE

Side Effect Reports % Deaths Hosp.
Osteonecrosis of jaw 313 19.1% 39 71
Drug ineffective 180 11.0% 15 61
Pain 164 10.0% 22 45
Off label use 143 8.7% 7 31
Pyrexia 106 6.5% 15 55
Malignant neoplasm progression 103 6.3% 33 17
Dyspnoea 102 6.2% 22 47
Fatigue 97 5.9% 23 33
Pain in jaw 97 5.9% 13 22
Metastases to bone 95 5.8% 21 26
Back pain 91 5.6% 15 39
Anxiety 89 5.4% 21 37
Death 89 5.4% 89 14
Nausea 89 5.4% 19 37
Arthralgia 87 5.3% 17 29

Other Indications for PAMIDRONATE

Product used for unknown indication (304) Plasma cell myeloma (173) Hypercalcaemia (172) Metastases to bone (116) Osteoporosis (88) Breast cancer (82) Breast cancer metastatic (68) Osteogenesis imperfecta (68) Hypercalcaemia of malignancy (39) Complex regional pain syndrome (25)

Other Drugs Used for Bone density decreased

ALENDRONATE (285) DENOSUMAB (169) TERIPARATIDE (159) ZOLEDRONIC ACID (104) IBANDRONATE (54) RISEDRONATE (42) ALENDRONATE\CHOLECALCIFEROL (29) ROMOSOZUMAB-AQQG (23) ALENDRONIC ACID (22) RALOXIFENE (16)

Related Pages

PAMIDRONATE Full Profile All Bone density decreased Drugs PAMIDRONATE Demographics PAMIDRONATE Timeline